Pune, India -- (SBWIRE) -- 02/21/2018 -- The report on Rheumatology Therapeutics Market by Drug Class (disease modifying anti-rheumatic, nonsteroidal anti-inflammatory, corticosteroids, uric acid drugs), by Disease Indication (rheumatoid arthritis, osteoarthritis, gout, psoriatic arthritis, ankylosing spondylitis), and by Distribution Channel (hospital, retail, online pharmacy) trends analysis and forecasts up to 2024 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Rheumatology Therapeutics Market is projected to grow at a CAGR of 2.52% in terms of value over the period of 2018-2024.

Get 15% discount for Global rheumatology therapeutics Market: https://www.infiniumglobalresearch.com/Reports/requestdiscount/1129

The recent report on global rheumatology therapeutics market identified that North America dominated the global rheumatology therapeutics market over the last couple of years, while emerging markets of Asia-Pacific and Latin America are anticipated to contribute significantly to the growth in the rheumatology therapeutics Market worldwide. Increasing incidences of rheumatic arthritis in North America and Europe owing to rising pool of geriatric population is a primary factor driving the growth in the world market. Furthermore, growing per capita healthcare expenditure coupled with rising number of patients over 50 years of age are likely to offer susbtantail growth opportunities in the Asia-Pacific region, as a result the Asia-Pacific rhematology therapeutics market is expected to grow at the highest CAGR over the forecast period-identifies Infinium Global Research.

Moreover, the growth matrix presented by Infinium Global Research identifies the key investment markets in the near future, this will not only help the companies to understand the competitive position in the global rheumatology therapeutics market but also make strategic decisions to capture the most lucrative markets in the near future.

The market size is presented in terms of value for the historic year 2016 and estimated for forecast period of 2018 to 2024.The report segments the global rheumatology therapeutics market on the basis of drug class, disease indication, and distribution channel.

Get Free Sample Pages of this Report: https://www.infiniumglobalresearch.com/Reports/MakeSampleRequest/1129

Global Rheumatology Therapeutics Market by Drug Class
- Disease Modifying Anti-rheumatic Drugs
- Nonsteroidal Anti-inflammatory Drugs
- Corticosteroids
- Uric Acid Drugs
- Others

Global Rheumatology Therapeutics Market by Disease Indication
- Rheumatoid Arthritis
- Osteoarthritis
- Gout
- Gout
- Ankylosing Spondylitis
- Others

Global Rheumatology Therapeutics Market by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy

Global Rheumatology Therapeutics Market by Regions
- North America
- Europe
- Asia-Pacific
- RoW

Companies Profiled in the report
- Takeda Pharmaceutical
- Sanofi
- Genentech, Inc.
- Novartis AG
- Janssen Biotech, Inc.
- Amgen, Inc.
- AbbVie, Inc.
- Pfizer, Inc.
- Bristol-Myers Squibb Company
- Merck & Co., Inc

Browse Complete TOC of this Report: https://www.infiniumglobalresearch.com/healthcare_medical_devices/global_rheumatology_therapeutics_market

About Infinium Global Research
Infinium Global Research is a business intelligence company that provides its clients with market information services, solutions, and reports. The intelligence reports include qualitative as well as quantitative information, which are blended using forecasting models in order to project future market demand. Our panels of Subject Matter Experts (SMEs), Analysts, and Consultants use numerous data gathering tools in order to provide you with detailed information on the market as well as a preview of its projected growth. Our repository includes the largest and most credible databases, through which we determine various qualitative and quantitative parameters of the market to provide you with an in-depth business intelligence report.